Acquired Company
KemPharm completed the sale of substantially all of Orphazyme's assets and business activities for USD 12.8 million in cash and assumed liabilities estimated to equal approximately USD 5.2 million on May 31, 2022.
Show more
Ole Maaloees Vej 3, Koebenhavn, 2200, Denmark
Start AI Chat
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$N/A
Open
$N/A
Volume
N/A
Day Range
$N/A - $N/A
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
09/30/24
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|